Literature DB >> 188769

Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75).

H Ben-Bassat, N Goldblum, S Mitrani, T Goldblum, J M Yoffey, M M Cohen, Z Bentwich, B Ramot, E Klein, G Klein.   

Abstract

The isolation and establishment in vitro of a hitherto undescribed type of lymphocyte designated D.G.-75 is reported. The original inoculum was derived from the pleural effusion of a child with a primary abdominal lymphoma, which clinically and histologically resembled Burkitt's lymphoma. In addition to the absence of the EBV genome and EBV receptors, this line possesses a number of other properties which distinguish it from previously described lymphoblastoid cell lines. It has different growth characteristics and morphology; does not form EAC or E rosettes (representative of B and T) cell surface markers, respectively); possesses IgM-kappa immunoglobulins on the cell surface (B lymphocyte), has an unusually high cap-forming ability and low agglutinability with fluorescent concanavalin A. One homologue of the No.14 chromosome pair possesses extra chromatin material as revealed on chromosome banding. This abnormal chromosome marker is similar to that described in biopsies and cultured tumor cells from patients with African Burkitt's lymphoma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 188769     DOI: 10.1002/ijc.2910190105

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  111 in total

1.  Epstein-Barr virus-encoded RK-BARF0 protein expression.

Authors:  N Kienzle; M Buck; S Greco; K Krauer; T B Sculley
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.

Authors:  L Zhang; J S Pagano
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

4.  Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.

Authors:  L C Spender; E J Cannell; M Hollyoake; B Wensing; J M Gawn; M Brimmell; G Packham; P J Farrell
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function.

Authors:  B J O'Sullivan; K P MacDonald; A R Pettit; R Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.

Authors:  Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.

Authors:  Martin Dufva; Josefine Flodin; Annika Nerstedt; Ulla Rüetschi; Lars Rymo
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

8.  Differentiation to myeloid cells of lymphoblastoid cells established from myelomonocytic leukemia.

Authors:  T Kimoto; F Hyodoh; K Nishitani; M Namba; A Ueki; Y Nishioka
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-10-03

9.  RBPJkappa-dependent signaling is essential for long-term maintenance of neural stem cells in the adult hippocampus.

Authors:  Oliver Ehm; Christian Göritz; Marcela Covic; Iris Schäffner; Tobias J Schwarz; Esra Karaca; Bettina Kempkes; Elisabeth Kremmer; Frank W Pfrieger; Lluis Espinosa; Anna Bigas; Claudio Giachino; Verdon Taylor; Jonas Frisén; D Chichung Lie
Journal:  J Neurosci       Date:  2010-10-13       Impact factor: 6.167

10.  Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.

Authors:  Eva M Campion; Roya Hakimjavadi; Sinéad T Loughran; Susan Phelan; Sinéad M Smith; Brendan N D'Souza; Rosemary J Tierney; Andrew I Bell; Paul A Cahill; Dermot Walls
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.